Treating Tobacco Dependence in Inpatient Psychiatry - 1
Tobacco Use Cessation, Tobacco Use Disorder
About this trial
This is an interventional treatment trial for Tobacco Use Cessation focused on measuring tobacco
Eligibility Criteria
Inclusion Criteria: Men and women over 18 years of age hospitalized on an inpatient psychiatric unit who report smoking at least 5 cigarettes per day; smoking at least 100 cigarettes in one's lifetime, residing in the San Francisco Bay Area with no plan to relocate outside of the area in the next 18 months, and access to a telephone for scheduling follow up assessments. Exclusion Criteria: Dementia or other brain injury precluding ability to participate; non-English speaking; severe agitation, psychosis, or hostility; and medical contraindications to nicotine replacement therapy (NRT). Recruitment of acutely psychotic, manic, or hostile patients will be delayed until there is significant reduction of these symptoms. Medical contraindications are: myocardial infarction in the preceding 3 months, unstable angina pectoris, liver or kidney disease, current pregnancy or breast feeding, allergies to adhesives, or other medical conditions that the medical team deems incompatible with NRT use.
Sites / Locations
- San Francisco General Hospital
- Langley Porter Psychiatric Institute
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
enhanced usual care control
stage-tailored intervention
NRT during hospitalization with brief advice to stay quit once discharged
NRT during hospitalization with brief advice to stay quit once discharged plus a computer-delivered stage-tailored smoking cessation intervention with manual and counseling plus 10-weeks of nicotine patch available post-hospitalization